Clinical Trials
4 trialsNCT03437941 2026-05-15
Study to Evaluate Exicorilant (CORT125281) in Combination With Enzalutamide in Patients With Metastatic Castration-Resistant Prostate Cancer
Corcept Therapeutics
Phase 1/2 Terminated
NCT05241613 2025-02-13
A Study of AC176 for the Treatment of Metastatic Castration Resistant Prostate Cancer
Accutar Biotechnology Inc
Phase 1 Terminated
NCT04869943 2024-01-26
ARTEST
Veru Inc.
Phase 3 Terminated
NCT05673109 2024-01-25
A Study of AC176 for the Treatment of Metastatic Castration Resistant Prostate Cancer
Accutar Biotechnology Inc
Phase 1 Terminated